Should a patient taking vinpocetine who develops new tinnitus and vertigo discontinue the medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Discontinue Vinpocetine Immediately

A patient taking vinpocetine who develops new tinnitus and vertigo should discontinue the medication immediately, as these symptoms represent potential adverse drug reactions that warrant cessation of the supplement.

Rationale for Discontinuation

The development of new tinnitus and vertigo in a patient taking vinpocetine creates a clear clinical scenario requiring medication discontinuation based on several key principles:

General Deprescribing Principles Apply

Any drug causing symptoms that have newly appeared should be stopped 1. The 2024 deprescribing guidelines explicitly state that "any drug for symptoms which have now resolved (eg, pain, nausea, vertigo, pruritus)" should be discontinued, and by extension, any drug potentially causing these symptoms warrants immediate reassessment and likely discontinuation.

Lack of Evidence for Vinpocetine Efficacy

The clinical practice guidelines for tinnitus management are unequivocal: clinicians should not recommend dietary supplements including Ginkgo biloba, melatonin, zinc, or other dietary supplements for treating patients with persistent, bothersome tinnitus 2. While vinpocetine is not specifically named, it falls squarely into the category of "other dietary supplements" with insufficient evidence for tinnitus treatment.

The guidelines emphasize avoiding supplements that have no proven benefit, particularly given potential side effects and false hope 2. The recommendation is based on RCTs and systematic reviews showing a preponderance of benefit in avoiding these supplements rather than using them.

Contradictory Research Evidence

While one small retrospective study from 2008 suggested vinpocetine combined with physiotherapy might be effective for chronic tinnitus 3, this conflicts with:

  • A 2021 study that showed vinpocetine may improve hearing in sensorineural hearing loss 4
  • A 2004 study showing vinpocetine prevented hearing loss in an experimental model 5

The critical issue is temporal relationship: If tinnitus and vertigo developed after starting vinpocetine, this suggests an adverse reaction rather than treatment failure. Drug-induced tinnitus is well-documented across multiple medication classes 6, 7.

Audio-Vestibular Side Effects Are Recognized

The literature on drug-induced audio-vestibular toxicity confirms that tinnitus, vertigo, and related symptoms can be medication-induced 7, 8. When these symptoms emerge temporally related to drug initiation, the medication becomes the prime suspect.

Clinical Algorithm

  1. Immediate discontinuation of vinpocetine
  2. Monitor for symptom resolution over 2-4 weeks after discontinuation
  3. If symptoms persist beyond 4 weeks, proceed with comprehensive audiologic evaluation as recommended for persistent tinnitus 2
  4. Evaluate for other causes including:
    • Unilateral vs bilateral presentation (unilateral requires imaging) 2
    • Associated hearing loss (requires prompt audiologic examination) 2
    • Other medications that may cause ototoxicity 6, 7

Common Pitfalls to Avoid

  • Do not continue vinpocetine "to see if it helps" - there is no evidence supporting its use for tinnitus, and it may be causing the symptoms
  • Do not substitute other supplements - the guidelines recommend against Ginkgo biloba, melatonin, zinc, and other dietary supplements for tinnitus 2
  • Do not delay audiologic evaluation if symptoms persist after discontinuation, particularly if tinnitus is unilateral or associated with hearing difficulties 2

Evidence-Based Alternatives If Symptoms Persist

Should tinnitus remain bothersome after vinpocetine discontinuation:

  • Cognitive-behavioral therapy (CBT) - strongly recommended based on RCTs 2
  • Hearing aid evaluation if hearing loss is present - recommended based on observational studies showing benefit 2
  • Sound therapy - may be recommended for persistent symptoms 2
  • Education and counseling about management strategies 2

Avoid routine use of antidepressants, anticonvulsants, or anxiolytics for primary tinnitus treatment, as these lack sufficient evidence and carry significant side effect risks 2.

References

2
Guideline

clinical practice guideline: tinnitus executive summary.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2014

3
Research

Multimodal therapy for chronic tinnitus.

The international tinnitus journal, 2008

5
Research

Vinpocetine prevents 4-aminopyridine-induced changes in the EEG, the auditory brainstem responses and hearing.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2004

6
Research

Analysis of Drug-Related Tinnitus Based on the FDA Adverse Event Reporting System Database.

British journal of hospital medicine (London, England : 2005), 2024

7
Research

Drugs inducing hearing loss, tinnitus, dizziness and vertigo: an updated guide.

European review for medical and pharmacological sciences, 2020

Related Questions

Is ear fullness and tinnitus a dangerous side effect of venlafaxine (Effexor), and can I continue the medication if these symptoms are mild?
Can tinnitus associated with Effexor (venlafaxine) be caused by my ear problem?
Can venlafaxine (Effexor XR) 37.5 mg cause or worsen tinnitus in a patient with pre-existing ear problems?
Can lisinopril cause tinnitus and a sensation of echoing in the ears?
Can a 37.5 mg dose of venlafaxine (Effexor XR) cause tinnitus?
Is MRI of the hip a diagnostic test for piriformis syndrome, or is piriformis syndrome primarily a clinical diagnosis?
For a 90‑day treatment requiring two tablets per month, how many tablets should be prescribed?
Is an intravenous iron infusion indicated for a ferritin level of 29.8 ng/mL?
What is the best benzodiazepine for treating anxiety in adults?
What is the appropriate management for a severe malaria patient with total bilirubin 28 mg/dL (direct 14 mg/dL, indirect 14 mg/dL), AST 195 U/L, ALT 224 U/L, normal renal function (creatinine 0.8 mg/dL, urea 14 mg/dL) and glucose 87 mg/dL?
What is the total number of tablets to prescribe for a regimen of two tablets twice daily for a 30‑day course?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.